Targeted focal therapy with magnetic resonance imaging (MRI)-guided focused ultrasound ablation is feasible for the treatment of intermediate-risk prostate cancer, according to a study published online Feb. 2 in Radiology. Sangeet Ghai, M.D., from the University of Toronto, and colleagues conducted a prospective phase II trial involving men with unifocal clinically significant prostate cancer visible at...